NEW YORK, Sept. 29, 2026 /PRNewswire/ — 120/80 Health Group today announced an eighth-year of record growth, driven by a broad slate of new client partnerships and continued expansion of long-standing relationships with leading innovators in healthcare and life sciences.

The results reflect 120/80 Health Group’s evolution from a communications firm driving brand awareness for early-to-growth stage digital health startups – into a strategic consultancy known for delivering measurable business outcomes for pre-series A to publicly traded businesses.  The agency’s exclusive focus on healthcare and life sciences provides a depth of industry knowledge that brokers business relationships, brings breakthrough ideas to market, accelerates adoption, builds category leadership, and creates sustainable growth and valuation.

In 2026, the firm added multiple category leaders across its two portfolio agencies. Importantly, it has also begun working with multiple top-10 global biopharmaceutical and diagnostic companies whose use of AI is transforming how new medicines, tests and devices are discovered, developed and brought to market.

“Healthcare innovation is entering an era in which intelligence will be embedded in every company, clinical workflow and patient experience,” said Rob Cronin, CEO of 120/80 Health Group. “But innovation only matters when people understand it, trust it and use it. Our growth reflects the trust clients place in us to help turn consequential ideas into adoption, market leadership and enterprise value. That is the standard we are building the Group around. Our purpose is clear – that no healthcare innovation fails to reach those who need it.”

Investing in Leadership That Advances Client Growth

To support its next stage, 120/80 Health Group is aligning and expanding its leadership team:

• Randi Liodice has joined the firm as chief growth officer and with a mandate centered on helping clients grow;
• Paula DeGangi has been promoted to lead AOx3 as chief client officer and managing partner;
• Mike Fay has been named Group chief strategy officer and managing partner;
• Jen Long continues to lead 120/80 as chief client officer and managing partner as well as leading the financial communications practice.

An Evolved Platform Built Around the Client Challenge

As a supporting expression of the business it has already built, the company has formalized 120/80 Health Group as its enterprise identity and introduced an evolved market position: The business outcomes partner to healthcare innovators.

The 120/80 and AOx3 brands will continue to serve clients with distinct expertise, relationships and teams, while providing access to the broader Group’s technology, strategies and practices. The company’s evolved story, capabilities and client work are featured on its newly launched website at www.12080healthgroup.com.

About 120/80 Health Group

120/80 Health Group is a business outcomes partner to healthcare innovators. Through 120/80, AOx3 and an expanding platform of integrated capabilities, the Group unites the right talent, technology, strategies and services around the critical challenges that determine whether innovation succeeds. Its purpose is simple: that no healthcare innovation fails to reach those who need it. Learn more at www.12080healthgroup.com.

Media Contact:
Alex McKechnie
120/80 Health Group
475.399.4056
alex.mckechnie@12080group.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/12080-health-group-marks-record-growth-driven-by-demand-from-health-and-life-sciences-302892664.html

SOURCE 120/80 Health Group